dc.contributor.author | Arnau Collell, Coral | |
dc.contributor.author | Soares de Lima, Yasmin | |
dc.contributor.author | Díaz Gay, Marcos | |
dc.contributor.author | Muñoz, Jenifer | |
dc.contributor.author | Carballal, Sabela | |
dc.contributor.author | Bonjoch, Laia | |
dc.contributor.author | Moreira, Leticia | |
dc.contributor.author | Lozano, Juan José | |
dc.contributor.author | Ocaña, Teresa | |
dc.contributor.author | Cuatrecasas, Miriam | |
dc.contributor.author | Díaz de Bustamante, Aranzazu | |
dc.contributor.author | Castells, Antoni | |
dc.contributor.author | Capella, Gabriel | |
dc.contributor.author | Bujanda Fernández de Pierola, Luis | |
dc.contributor.author | Cubiella, Joaquín | |
dc.contributor.author | Rodríguez Alcalde, Daniel | |
dc.contributor.author | Balaguer, Francesc | |
dc.contributor.author | Ruiz Ponte, Clara | |
dc.contributor.author | Valle, Laura | |
dc.contributor.author | Moreno, Víctor | |
dc.contributor.author | Castellví Bel, Sergi | |
dc.date.accessioned | 2021-02-16T09:36:17Z | |
dc.date.available | 2021-02-16T09:36:17Z | |
dc.date.issued | 2020-10 | |
dc.identifier.citation | Journal Of Medical Genetics 57(10) : 677-682 (2020) | es_ES |
dc.identifier.issn | 0022-2593 | |
dc.identifier.issn | 1468-6244 | |
dc.identifier.uri | http://hdl.handle.net/10810/50192 | |
dc.description.abstract | Background Serrated polyposis syndrome (SPS) is a clinical entity characterised by large and/ormultiple serrated polyps throughout the colon and increased risk for colorectal cancer (CRC). The basis for SPS genetic predisposition is largely unknown. Common, low-penetrance genetic variants have been consistently associated with CRC susceptibility, however, their role in SPS genetic predisposition has not been yet explored. Objective The aim of this study was to evaluate if common, low-penetrance genetic variants for CRC risk are also implicated in SPS genetic susceptibility. Methods A case-control study was performed in 219 SPS patients and 548 asymptomatic controls analysing 65 CRC susceptibility variants. A risk prediction model for SPS predisposition was developed. Results Statistically significant associations with SPS were found for seven genetic variants (rs4779584-GREM1, rs16892766-EIF3H, rs3217810-CCND2, rs992157-PNKD1/TMBIM1, rs704017-ZMIZ1, rs11196172-TCF7L2, rs6061231-LAMA5). TheGREM1risk allele was remarkably over-represented in SPS cases compared with controls (OR=1.573, 1.21-2.04, p value=0.0006). A fourfold increase in SPS risk was observed when comparing subjects within the highest decile of variants (>= 65) with those in the first decile (<= 50). Conclusions Genetic variants for CRC risk are also involved in SPS susceptibility, being the most relevant ones rs4779584-GREM1, rs16892766-EIF3Hand rs3217810-CCND2. | es_ES |
dc.description.sponsorship | CA--C, JM and JJL were supported by a contract from CIBEREHD. YSdL was supported by a fellowship (LCF/BQ/DI18/11660058) from 'la Caixa' Foundation (ID 100010434) funded EU Horizon 2020 Programme (Marie Sklodowska-Curie grant agreement no. 713673). LB was supported by a Juan de la Cierva postdoctoral contract (FJCI-2017-32593) and MD-G by a contract from Agencia de Gestio d'Ajuts Universitaris i de Recerca, AGAUR, (Generalitat de Catalunya, 2018FI_B1_00213). CIBEREHD, CIBERER, CIBERESP and CIBERONC are funded by the Instituto de Salud Carlos III. This research was supported by grants from Fondo de Investigacion Sanitaria/FEDER (14/00613, 16/00766, 17/00509, 17/00878), Fundacion Cientifica de la Asociacion Espanola contra el Cancer (GCB13131592CAST), Spanish Ministry of Science, Innovation and Universities, co-funded by FEDER funds, (SAF201680888--R), PERIS (SLT002/16/00398, SLT002/16/0037, Generalitat de Catalunya), CERCA Programme (Generalitat de Catalunya) and Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya, GRPRE 2017SGR21, GRC 2017SGR653, 2017SGR1282, 2017SGR723). This article is based upon work from COST Action CA17118, supported by European Cooperation in Science and Technology (COST). www.cost.eu. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | BMJ Publishing Group | es_ES |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/713673 | es_ES |
dc.relation | info:eu-repo/grantAgreement/MICIU/SAF2016-80888-R | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/es/ | * |
dc.subject | serrated polyposis syndrome | es_ES |
dc.subject | colorectal cancer | es_ES |
dc.subject | genetic association study | es_ES |
dc.subject | low-penetrance genetic variant | es_ES |
dc.subject | genetic predisposition to disease | es_ES |
dc.subject | germline RNF43 mutations | es_ES |
dc.subject | loci | es_ES |
dc.title | Colorectal Cancer Genetic Variants Are Also Associated with Serrated Polyposis Syndrome Susceptibility | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) | es_ES |
dc.rights.holder | Atribución-NoComercial 3.0 España | * |
dc.relation.publisherversion | https://jmg.bmj.com/content/57/10/677.long | es_ES |
dc.identifier.doi | 10.1136/jmedgenet-2019-106374 | |
dc.contributor.funder | European Commission | |
dc.departamentoes | Medicina | es_ES |
dc.departamentoeu | Medikuntza | es_ES |